Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Florence
Clinical trial register · Italy

Clinical Trials in Florence, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 50 Naples 37 Roma 24 Pisa 17 Florence 17
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca57 Meyer Children's Hospital IRCCS41 Merck Sharp & Dohme LLC25 Eli Lilly and Company25 Novartis Pharmaceuticals24 Clear sponsor filter
Site location
Milan50 Naples37 Roma24 Pisa17 Florence17
All 69 locations
Target enrolment
to

Trials with a site in Florence

17 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Florence, Palermo
2026-12-16
Active, closed
Bristol-Myers Squibb
Phase 2
76
Meldola, Udine, Bergamo, Florence, Novara
2025-09-19
Recruiting
Bristol-Myers Squibb
Phase 3
60
Naples, Florence
2025-03-13
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Aviano, Milan, Candiolo, Florence, Roma
2025-02-04
Active, closed
Bristol-Myers Squibb
Phase 3
44
Florence, Genova, Naples
2024-04-17
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Ancona, Modena, Florence, Milan, Pisa, Roma, Trieste, Bergamo
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Rome, Milan, Rozzano, Turin, Florence, Bologna, Reggio Calabria, Roma
2023-10-24
Active, closed
Bristol-Myers Squibb
Phase 3
106
Reggio Calabria, Naples, Rome, Pavia, Rozzano (MI), Novara, Turin, Florence
2023-10-05
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Bologna, Modena, Florence, Milan, Pisa, Roma, Ancona, Bergamo
2023-09-14
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Catania, Florence, Genova, Milan, Pisa, Roma, Torino, Naples
2023-06-22
Active, closed
Bristol-Myers Squibb
Phase 2/3
230
Rome, Rozzano, Florence, Bologna
2022-12-14
Active, closed
Bristol-Myers Squibb
Phase 3
729
Florence, Potenza, Roma
2021-07-15
Active, closed
Bristol-Myers Squibb
Phase 3
681
Cremona, Florence, Meldola, Milan, Padova, Parma, Pavia, Roma
2021-05-21
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Bologna, Brescia, Florence, Verona
2021-03-22
Active, closed
Bristol-Myers Squibb
Phase 3
545
Messina, Bologna, Florence, Meldola, Milan, Modena, Monserrato, Naples
2018-04-18
Active, closed
Bristol-Myers Squibb
Observational
800
Florence, Genova, Naples, Padova, Trento
2013-01-30
Active, closed
Bristol-Myers Squibb
Observational
2,555
Pesaro, Ancona, Cagliari, Florence, Lecce, Messina, Milan, Naples
2012-06-13
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/florence

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Florence that also match the filters currently applied.

How many clinical trials are recruiting in Florence?

2 of the 17 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Florence), 17 studies
PhaseStudiesRecruitingShare
Phase 311164.7%
Observational2011.8%
Phase 1/22111.8%
Phase 2105.9%
Phase 2/3105.9%

Most active sponsors

Lead sponsors with the most studies (Florence)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb172
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.